On January 7, 2019 Biological Dynamics, a company committed to improving global health outcomes through empowering global communities with accessible cancer diagnostics, reported the company will present at the Biotech Showcase 2019 conference, taking place during the annual J.P. Morgan Healthcare Conference on January 7-9 at the Hilton San Francisco Union Square (Press release, Biological Dynamics, JAN 7, 2019, View Source [SID1234532544]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Raj Krishnan, Ph.D., CEO of Biological Dynamics, will present at the Biotech Showcase as follows:
Date: Tuesday, January 8, 2019
Time: 1:30 p.m. (PST)
Room: Franciscan B
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, Calif.
Dr. Krishnan will present an overview of Biological Dynamics’ innovative cancer diagnostics platform, Verita, as well as the company’s plans to transition into a commercial-stage company and further the development of a smartphone-enabled diagnostics platform.
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and executives in one place. This event takes place during the industry’s most prevalent healthcare investor conference, the annual J.P. Morgan Healthcare Conference